Trials / Completed
CompletedNCT00629044
Genetic Polymorphysm of Cholesterol 24 S Hydroxylase in Patients With Glaucoma and AMD
Etude du Polymorphysme génétique de la cholestérol 24S Hydroxylase et Des Teneurs en 24S hydroxycholestérol Chez Des Patients Atteints de Glaucome ou de dégénérescence Maculaire liée à l'âge.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 320 (estimated)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to assess the implicitement of the cholesterol 24 S hydroxylase gene and the 24 S hydroxycholesterol in glaucoma and in age related macular degeneration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Assessing the blood level of cholesterol 24 S Hydroxylase | Comparison of venous blood level of Cholesterol 24 S hydroxylase and 24 hydroxycholesterol in patients with Glaucoma and AMD and in healthy subjects. |
| BIOLOGICAL | Assessing the blood level of cholesterol 24 S hydroxylase | Comparison of venous blood level of cholesterol 24 S hydroxylase and 24 hydroxycholesterol in patients with Glaucoma, AMD end in healthy subjects |
| BIOLOGICAL | assessing the blood level of cholesterol 24 S hydroxylase | Comparison of venous blood level of cholesterol 24 S hydroxylase and 24 hydroxycholesterol in patients with glaucoma, AMD and in healthy subjects |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2009-11-01
- Completion
- 2011-01-01
- First posted
- 2008-03-05
- Last updated
- 2011-03-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00629044. Inclusion in this directory is not an endorsement.